UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription

Journal of experimental & clinical cancer research, 2022-08, Vol.41 (1), p.1-261, Article 261

2022

Volltextzugriff (PDF)

Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer

BMC cancer, 2022-01, Vol.22 (1), p.6-6, Article 6

2022

Volltextzugriff (PDF)

Clinical characteristics and treatment outcomes of women with recurrent uterine leiomyosarcoma

Orphanet journal of rare diseases, 2024-10, Vol.19 (1), p.395-9, Article 395

2024

Volltextzugriff (PDF)

Strategies for Energy-Aware Multi-agent Continuous Cooperative Patrolling Problems Subject to Requirements

PRIMA 2019: Principles and Practice of Multi-Agent Systems, p.585-593

Volltextzugriff (PDF)

Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model

Frontiers in oncology, 2021-09, Vol.11, p.711020-711020

2021

Volltextzugriff (PDF)

Diagnostic value of circN4BP2L2 in type I and type II epithelial ovarian cancer

BMC cancer, 2022-11, Vol.22 (1), p.1210-1210, Article 1210

2022

Volltextzugriff (PDF)

Subsequent management and outcomes after first-line PARP inhibitors progression in ovarian cancer patients

Journal of ovarian research, 2024-04, Vol.17 (1), p.70-70, Article 70

2024

Volltextzugriff (PDF)

Clinicopathologic features and prognostic analysis of stage I ovarian clear cell cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e17090-e17090

2019

Volltextzugriff (PDF)

Primary malignant melanoma of the cervix: Report of 14 cases and review of literature

Oncotarget, 2017-09, Vol.8 (42), p.73162-73167

2017

Volltextzugriff (PDF)

Evaluation of the sexual quality of life and sexual function of cervical cancer survivors after cancer treatment: a retrospective trial

Archives of gynecology and obstetrics, 2021-10, Vol.304 (4), p.999-1006

2021

Volltextzugriff (PDF)

Occurrence of Aflatoxin M1 in Three Types of Milk from Xinjiang, China, and the Risk of Exposure for Milk Consumers in Different Age-Sex Groups

Foods, 2022-12, Vol.11 (23), p.3922

2022

Volltextzugriff (PDF)

The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients

International journal of gynecological cancer, 2017-10, Vol.27 (8), p.1650-1657

2017

Volltextzugriff (PDF)

CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination

Journal of nanobiotechnology, 2024-01, Vol.22 (1), p.35-35, Article 35

2024

Volltextzugriff (PDF)

Upregulation of NOD1 and NOD2 contribute to cancer progression through the positive regulation of tumorigenicity and metastasis in human squamous cervical cancer

BMC medicine, 2022-02, Vol.20 (1), p.55-55, Article 55

2022

Volltextzugriff (PDF)

PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer

Journal of Gynecologic Oncology, 2024, 35(4), , pp.1-12

2024

Volltextzugriff (PDF)

Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer

Cancer cell international, 2022-03, Vol.22 (1), p.118-118, Article 118

2022

Volltextzugriff (PDF)

Prognostic Nomograms Predicting Survival in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: The First Nomogram Compared With Revised FIGO 2018 Staging System

Frontiers in oncology, 2020-10, Vol.10, p.591700-591700

2020

Volltextzugriff (PDF)

Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade

Journal of experimental & clinical cancer research, 2024-02, Vol.43 (1), p.51-51, Article 51

2024

Volltextzugriff (PDF)

High expression of RARG accelerates ovarian cancer progression by regulating cell proliferation

Frontiers in oncology, 2022-11, Vol.12, p.1063031-1063031

2022

Volltextzugriff (PDF)

Correction: Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade

Journal of experimental & clinical cancer research, 2024-04, Vol.43 (1), p.113-113, Article 113

2024

Volltextzugriff (PDF)

Patient Assessment and Therapy Planning Based on Homologous Recombination Repair Deficiency

Genomics, proteomics & bioinformatics, 2023-10, Vol.21 (5), p.962-975

2023

Volltextzugriff (PDF)

Long-Term Survival and Late Toxicity Associated With Pelvic Intensity Modulated Radiation Therapy (IMRT) for Cervical Cancer Involving CT-Based Positive Lymph Nodes

Frontiers in oncology, 2019-06, Vol.9, p.520

2019

Volltextzugriff (PDF)

Dietary addition of fermented sorghum distiller’s dried grains with soluble improves carcass traits and meat quality in growing-finishing pigs

Tropical animal health and production, 2022-04, Vol.54 (2), p.97-97, Article 97

2022

Volltextzugriff (PDF)

Long non-coding RNA profiling in LPS-induced intestinal inflammation model: New insight into pathogenesis

Innate immunity (London, England), 2019-11, Vol.25 (8), p.491-502

2019

Volltextzugriff (PDF)

Efficacy and safety of serplulimab plus nab-paclitaxel in previously treated patients with PD-L1-positive advanced cervical cancer: a phase II, single-arm study

Frontiers in immunology, 2023-04, Vol.14, p.1142256

2023

Volltextzugriff (PDF)

1 – 25 von 307

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(265)
Mit Volltextzugriff
(270)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription

Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer

Clinical characteristics and treatment outcomes of women with recurrent uterine leiomyosarcoma

Strategies for Energy-Aware Multi-agent Continuous Cooperative Patrolling Problems Subject to Requirements

Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model

Diagnostic value of circN4BP2L2 in type I and type II epithelial ovarian cancer

Subsequent management and outcomes after first-line PARP inhibitors progression in ovarian cancer patients

Clinicopathologic features and prognostic analysis of stage I ovarian clear cell cancer

Primary malignant melanoma of the cervix: Report of 14 cases and review of literature

Evaluation of the sexual quality of life and sexual function of cervical cancer survivors after cancer treatment: a retrospective trial

Occurrence of Aflatoxin M1 in Three Types of Milk from Xinjiang, China, and the Risk of Exposure for Milk Consumers in Different Age-Sex Groups

The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients

CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination

Upregulation of NOD1 and NOD2 contribute to cancer progression through the positive regulation of tumorigenicity and metastasis in human squamous cervical cancer

PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer

Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer

Prognostic Nomograms Predicting Survival in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: The First Nomogram Compared With Revised FIGO 2018 Staging System

Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade

High expression of RARG accelerates ovarian cancer progression by regulating cell proliferation

Correction: Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade

Patient Assessment and Therapy Planning Based on Homologous Recombination Repair Deficiency

Long-Term Survival and Late Toxicity Associated With Pelvic Intensity Modulated Radiation Therapy (IMRT) for Cervical Cancer Involving CT-Based Positive Lymph Nodes

Dietary addition of fermented sorghum distiller’s dried grains with soluble improves carcass traits and meat quality in growing-finishing pigs

Long non-coding RNA profiling in LPS-induced intestinal inflammation model: New insight into pathogenesis

Efficacy and safety of serplulimab plus nab-paclitaxel in previously treated patients with PD-L1-positive advanced cervical cancer: a phase II, single-arm study

Suchergebnisse filtern